Cargando…

Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma

OBJECTIVE: This study aimed to evaluate the predictive value of gadoxetic acid disodium magnetic resonance imaging (MRI) in the microvascular invasion (MVI) of hepatocellular carcinoma (HCC). METHODS: 87 HCC patients (2019-01–2022-01) admitted to the hospital were selected for retrospective analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiao, Ming, Xianfang, Wang, Zhen, Ye, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534666/ https://www.ncbi.nlm.nih.gov/pubmed/36247863 http://dx.doi.org/10.1155/2022/6128845

Ejemplares similares

Predicting microvascular invasion in hepatocellular carcinoma: A dual‐institution study on gadoxetate disodium‐enhanced MRI
por: Jiang, Hanyu, et al.
Publicado: (2022)

Multi-scale and multi-parametric radiomics of gadoxetate disodium–enhanced MRI predicts microvascular invasion and outcome in patients with solitary hepatocellular carcinoma ≤ 5 cm
por: Chong, Huan-Huan, et al.
Publicado: (2021)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
por: Yang, Ting, et al.
Publicado: (2023)

Value of gadoxetic acid-enhanced MRI for microvascular invasion of small hepatocellular carcinoma: a retrospective study
por: Zhou, Meng, et al.
Publicado: (2021)

Peritumoral Dilation Radiomics of Gadoxetate Disodium-Enhanced MRI Excellently Predicts Early Recurrence of Hepatocellular Carcinoma without Macrovascular Invasion After Hepatectomy
por: Chong, Huanhuan, et al.
Publicado: (2021)

Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging for the Detection of Hepatocellular Carcinoma: A Meta-Analysis
por: Liu, Xijiao, et al.
Publicado: (2013)

Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study
por: Rao, Chenyi, et al.
Publicado: (2020)

Preoperative prediction of glypican-3 positive expression in solitary hepatocellular carcinoma on gadoxetate-disodium enhanced magnetic resonance imaging
por: Chen, Yidi, et al.
Publicado: (2022)

The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in detecting hepatocellular carcinoma: A meta-analysis
por: Wang, Jiming, et al.
Publicado: (2021)

Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation
por: Zhang, Ling, et al.
Publicado: (2021)

Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers
por: Lochrin, Sarah E., et al.
Publicado: (2021)

Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC
por: Cannella, Roberto, et al.
Publicado: (2022)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
por: Ricke, Jens, et al.
Publicado: (2020)

Influence of age on gadoxetic acid disodium-induced transient respiratory motion artifacts in pediatric liver MRI
por: Hojreh, Azadeh, et al.
Publicado: (2022)

Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study
por: Ichikawa, Shintaro, et al.
Publicado: (2020)

Safety profile of gadoxetate disodium in elderly patients (≥65 years)
por: Endrikat, Jan, et al.
Publicado: (2017)

Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI
por: Palm, Viktoria, et al.
Publicado: (2018)

Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver
por: Huh, Jimi, et al.
Publicado: (2015)

Does gadoxetate disodium affect MRE measurements in the delayed hepatobiliary phase?
por: Plaikner, M., et al.
Publicado: (2018)

Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study
por: Ye, Zheng, et al.
Publicado: (2019)

Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver MRI
por: Song, Kyoung Doo, et al.
Publicado: (2015)

Diagnostic performance of contrast-enhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma: direct comparison and a meta-analysis
por: Guo, Jin, et al.
Publicado: (2016)

Shrunken Hepatic Hemangioma Following Delineated Peritumoral Hyperintensity on Gadoxetic Acid Disodium-enhanced MR Imaging
por: Haradome, Hiroki, et al.
Publicado: (2017)

Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis
por: Li, Xiang, et al.
Publicado: (2015)

Evaluation of transient respiratory motion artifact at gadoxetate disodium-enhanced MRI—Influence of different contrast agent application protocols
por: Ringe, Kristina I., et al.
Publicado: (2018)

Gadoxetate Disodium enhanced spectral dual-energy CT for evaluation of cholangiocarcinoma: Preliminary data
por: Thomas, John V., et al.
Publicado: (2016)

Characteristics of Hepatic Schwannoma Presenting as an Unusual Multi-cystic Mass on Gadoxetic Acid Disodium-enhanced MR Imaging
por: Haradome, Hiroki, et al.
Publicado: (2017)

Improved visualisation of hepatic metastases in gadoxetate disodium-enhanced MRI: Potential of contrast-optimised (phase-sensitive) inversion recovery imaging
por: Fahlenkamp, Ute Lina, et al.
Publicado: (2019)

Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction
por: Zhang, Zhen, et al.
Publicado: (2019)

Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria
por: Park, Jae Hyon, et al.
Publicado: (2020)

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients
por: Endrikat, Jan, et al.
Publicado: (2015)

Meta-Analysis of Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases
por: Chen, Lihua, et al.
Publicado: (2012)

Respiratory anomalies associated with gadoxetate disodium and gadoterate meglumine: compressed sensing MRI revealing physiologic phenomena during the entire injection cycle
por: Glessgen, Carl Guillaume, et al.
Publicado: (2021)

Relative Enhancement in Gadoxetate Disodium-Enhanced Liver MRI as an Imaging Biomarker in the Diagnosis of Non-Alcoholic Fatty Liver Disease in Pediatric Obesity
por: Hojreh, Azadeh, et al.
Publicado: (2023)

Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma
por: Qiu, Ganbin, et al.
Publicado: (2023)

A rare case of MRI of myxoid hepatocellular adenoma with gadoxetic acid uptake
por: Yang, Tze Wei Wilson, et al.
Publicado: (2023)

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma via Multi-Parametric MRI Radiomics
por: Zhang, Yang, et al.
Publicado: (2021)

The diagnostic performance of radiomics-based MRI in predicting microvascular invasion in hepatocellular carcinoma: A meta-analysis
por: Liang, Gao, et al.
Publicado: (2023)

Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers
por: Kim, Yeun-Yoon, et al.
Publicado: (2019)

LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid–enhanced MRI for early recurrence risk stratification after curative resection
por: Wei, Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3v88fh9l6n01e91dtvg255cffr